In this study, we examine whether cognitive status (normal cognition, mild cognitive impairment, and dementia) is associated with albuminuria, a microvascular disorder of the kidney.
There were significant improvements in cognition [COGNISTAT (Neurobehavioral Cognitive Status Examination) and MMSE (Mini-Mental State Examination)] for the treatment group compared with the control group (p < 0.01).
Among statin-naive AMI patients age ≥ 65 years in a multicenter US registry, we examined the association between statin prescription at discharge and change in cognition (via Modified Telephone Interview for Cognitive Status [TICS-M]) assessed at 1 and 6 months after AMI.
Cognitive functioning assessed two independent factors of cognition: mental status (orientation, registration, and attention) and memory (immediate verbal memory).
A significant interaction existed between cognition, group status, and time for depression as a secondary outcome.
10, 12, 14, 19– 21 Generally, appropriate therapeutic goals for older patients with T2DM should be determined based on comprehensive evaluation of cognition, functional status, comorbidities including cardiovascular risk, and geriatric syndromes.
Women and men also showed significant differences in circulating levels of IGFBP3 and the IGF-1/IGFPB3 molar ratio as well as in scores for cognition, functional status and circulating levels of free triiodothyronine (Table 1).
This information will provide novel and robust evidence for the efficacy of cognitive and strength training on cognition and functional status in at risk older adults.
Cognition and functional status were assessed using measures of selective attention, episodic memory, cognitive flexibility and instrumental and basic activities of daily living.
Indicators of heath status, including cognition (global cognition and five specific cognitive abilities), functional status (basic and instrumental activities of daily living, mobility disability), and mental health (depressive symptoms, loneliness) were assessed.
